Literature DB >> 33566191

Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomal MicroRNA-18b-3p Inhibits the Occurrence of Preeclampsia by Targeting LEP.

Qin Huang1, Meng Gong1, Tuantuan Tan2, Yunong Lin3, Yan Bao1, Cuifang Fan4.   

Abstract

Exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs) expressing microRNAs have been highlighted in human diseases. However, the detailed molecular mechanism of hucMSCs-derived exosomal miR-18b-3p on preeclampsia (PE) remains further investigation. We aimed to investigate the effect of exosomes and miR-18b-3p/leptin (LEP) on occurrence of PE. The morphology of the hucMSC and hucMSC-exosomes (Exos) was identified. The exosomes were infected with different lentivirus expressing miR-18b-3p to explore the role of miR-18b-3p in PE. The PE rat model was established by intraperitoneal injection of N-nitro-L-arginine methyl ester. The expression of LEP and miR-18b-3p was tested in PE rat placenta tissues. Also, the effect of exosomes on LEP and miR-18b-3p expression was detected. The systolic blood pressure (SBP), proteinuria, inflammatory factors, the weight of fetal rat and placenta and cell apoptosis in PE rats were detected. Finally, the relationship between miR-18b-3p and LEP was verified using dual-luciferase reporter gene assay and RNA pull-down assay. Exosomes, restoring miR-18b-3p or inhibiting LEP reduced SBP and proteinuria of PE rats as well as increased the weight of fetal rat and placenta, decreased serum levels of inflammatory factors as well as suppressed apoptotic cells of PE rats, exerting a suppressive effect on PE progression. miR-18b-3p was decreased and LEP was increased in placenta tissues of PE rats. LEP was the direct target gene of miR-18b-3p. Upregulation of miR-18b-3p or treatment of the exosomes suppressed LEP expression and reduced PE occurrence, while downregulation of miR-18b-3p had contrary effects. Downregulated LEP reversed the effect of miR-18b-3p reduction on PE rats. HucMSCs-derived exosomal miR-18b-3p targets LEP to participate in the occurrence and development of PE. This study may provide a novel theoretical basis for the mechanism and investigation of PE.

Entities:  

Keywords:  Apoptosis; Exosomes; Human umbilical cord mesenchymal stem cells; Leptin; MicroRNA-18b-3p; Preeclampsia

Year:  2021        PMID: 33566191      PMCID: PMC7876216          DOI: 10.1186/s11671-021-03475-5

Source DB:  PubMed          Journal:  Nanoscale Res Lett        ISSN: 1556-276X            Impact factor:   4.703


  35 in total

1.  Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Meera Mody; Roberto Romero; Yi Xu; Katalin Karaszi; Noemi Mihalik; Zhonghui Xu; Gaurav Bhatti; Tibor Fule; Petronella Hupuczi; Tibor Krenacs; Janos Rigo; Adi L Tarca; Sonia S Hassan; Tinnakorn Chaiworapongsa; Ilona Kovalszky; Zoltan Papp; Nandor Gabor Than
Journal:  Pathol Oncol Res       Date:  2015-01-13       Impact factor: 3.201

2.  Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.

Authors:  Chi Zhou; Qing-Yun Zou; Hua Li; Rui-Fang Wang; Ai-Xia Liu; Ronald R Magness; Jing Zheng
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

3.  Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia.

Authors:  Michail Kalinderis; Alexis Papanikolaou; Kallirhoe Kalinderi; Elizabeth Ioannidou; Charalambos Giannoulis; Vasilis Karagiannis; Basil C Tarlatzis
Journal:  Am J Reprod Immunol       Date:  2011-05-30       Impact factor: 3.886

4.  A prospective cohort study on the clinical utility of second trimester mean arterial blood pressure in the prediction of late-onset preeclampsia among Nigerian women.

Authors:  I C Udenze; A P Arikawe; C C Makwe; O F Olowoselu
Journal:  Niger J Clin Pract       Date:  2017-06       Impact factor: 0.968

5.  Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.

Authors:  Francesca Sironi; Antonio Vallarola; Martina Bruna Violatto; Laura Talamini; Mattia Freschi; Roberta De Gioia; Chiara Capelli; Azzurra Agostini; Davide Moscatelli; Massimo Tortarolo; Paolo Bigini; Martino Introna; Caterina Bendotti
Journal:  Stem Cell Res       Date:  2017-11-10       Impact factor: 2.020

6.  Association of microRNA-155, interleukin 17A, and proteinuria in preeclampsia.

Authors:  Xu Yang; Jie Zhang; Yiling Ding
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 7.  Gastric Leptin and Tumorigenesis: Beyond Obesity.

Authors:  Kyoko Inagaki-Ohara
Journal:  Int J Mol Sci       Date:  2019-05-28       Impact factor: 5.923

8.  The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.

Authors:  Altaf A Dar; Shahana Majid; Claudia Rittsteuer; David de Semir; Vladimir Bezrookove; Schuyler Tong; Mehdi Nosrati; Richard Sagebiel; James R Miller; Mohammed Kashani-Sabet
Journal:  J Natl Cancer Inst       Date:  2013-01-30       Impact factor: 13.506

9.  miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer.

Authors:  Hironori Tanaka; Shoichi Hazama; Michihisa Iida; Ryouichi Tsunedomi; Hiroko Takenouchi; Masao Nakajima; Yukio Tokumitsu; Shinsuke Kanekiyo; Yoshitaro Shindo; Shinobu Tomochika; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Takeda; Shigeru Yamamoto; Shigefumi Yoshino; Tomio Ueno; Yoshihiko Hamamoto; Yusuke Fujita; Hiroaki Tanaka; Ko Tahara; Ryoichi Shimizu; Kiyotaka Okuno; Koji Fujita; Masahiko Kuroda; Yusuke Nakamura; Hiroaki Nagano
Journal:  Cancer Sci       Date:  2017-09-22       Impact factor: 6.716

10.  MicroRNA‑144‑3p may participate in the pathogenesis of preeclampsia by targeting Cox‑2.

Authors:  Suwei Hu; Jie Li; Ming Tong; Qian Li; Yong Chen; Hongmei Lu; Yixiong Wang; Lingfeng Min
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

View more
  5 in total

Review 1.  The pathological and therapeutic roles of mesenchymal stem cells in preeclampsia.

Authors:  Sanshan Jin; Canrong Wu; Ming Chen; Dongyan Sun; Hua Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-28

Review 2.  The exosome: a review of current therapeutic roles and capabilities in human reproduction.

Authors:  Marko Dimik; Pevindu Abeysinghe; Jayden Logan; Murray Mitchell
Journal:  Drug Deliv Transl Res       Date:  2022-08-18       Impact factor: 5.671

3.  Mast cell-derived exosomal miR-181a-5p modulated trophoblast cell viability, migration, and invasion via YY1/MMP-9 axis.

Authors:  Yinfen Wang; Aner Chen
Journal:  J Clin Lab Anal       Date:  2022-06-13       Impact factor: 3.124

Review 4.  Significance of Placental Mesenchymal Stem Cell in Placenta Development and Implications for Preeclampsia.

Authors:  Yang Zhang; Yanqi Zhong; Li Zou; Xiaoxia Liu
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 5.  Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes.

Authors:  Himadri Devvanshi; Rohit Kachhwaha; Anima Manhswita; Shinjini Bhatnagar; Pallavi Kshetrapal
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.